Statistics

Total Visits

Views
A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors 44
A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors 8

Total Visits per Month

September 2022 October 2022 November 2022 December 2022 January 2023 February 2023 March 2023
A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors 0 1 1 0 10 5 1

File Downloads

Views

Top Country Views

Views
United States 18
China 16
Netherlands 8
Australia 1
France 1
Vietnam 1

Top City Views

Views
Rotterdam 8
Ashburn 7
Zhengzhou 6
Beijing 4
Changchun 3
Fairfield 3
Des Moines 1
Hanoi 1
Kaleen 1
Qingping 1